Dallas-based BioLum Sciences has received another round of funding from Intelis Capital, which invests in early stage ventures.
The startup co-founded by Southern Methodist University graduates is working on a non-invasive device for asthma management. The device measures airway inflammation though a breath scan and will correspond with an app so patients and doctors can keep track of an individual’s health, according to the BioLum website.
The amount of this latest funding round was not disclosed, according to D CEO Healthcare’s Olivia Nguyen, BioLum did say the investment would be used for product development, commercialization, and the clinical trials it expects to begin next year.
“We have one ultimate goal for the rest of the year: to have a commercially viable device ready for clinical trials by 2018,” BioLum CEO and Co-founder Edward Allegra said in a statement to D CEO Healthcare.
Dallas Innovates, every day
One quick signup, and you’ll be on the list.